logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bo Zhang

National Cancer Center and Chinese Academy of Medical Sciences and Peking Union Medical College
H指数:18
被引数:1,426

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition)
TRANSLATIONAL PEDIATRICS
IF1.7
2025-11-010
PRE
Mo, Xiaolan; Deng, Houliang; Yang, Jinlian; Li, Jiale; Ouyang, Shan; Chen, Feng; Cui, Yanqin; Gao, Xia; Jiang, Hua; Li, Xiaojing; Liu, Li; Liu, Jie; Qiu, Lin; Rong, Xiaoming; Wen, Zhe; Wang, Jiayi; Zeng, Ping; Zhang, Wen; Zhao, Xiaopeng; Zhou, Juan; Chen, Jie; Chen, Pan; Chen, Wenying; Chen, Zebin; Fang, Rui; Fan, Xiaomei; Jia, Yuntao; Li, Zhiling; Li, Xuejuan; Li, Xiaoyan; Lin, Yunzhu; Liu, Maochang; Mai, Haiyan; Miao, Jing; Wang, Xiaoling; Wang, Yong; Wang, Jinghao; Wei, Li; Wu, Junyan; Yu, Shanshan; Zeng, Linan; Zhang, Bo; Zhang, Hongliang; Zheng, Zhihua; Chen, Xiao; Xia, Sujian; Zhou, Wenhao; Sun, Jing; Li, Yilei
Tumor-Boundary Response Index (TBRI)- A promising indicator for predicting outcomes in colorectal liver metastases receiving neoadjuvant therapy: Insights from a single-center retrospective study

肿瘤边界反应指数 (TBRI) - 一种预测接受新辅助治疗的结直肠癌肝转移患者预后的有前景的指标：单中心回顾性研究的见解

european journal of oncology
IF0
2025-06-240
PRE
Yin-Chen Gu; Mei Yang; Yan Geng; Bo Zhang; Bao-Rui Tao; Sen-Feng Ying; Rong-Quan Sun; Yi-Tong Li; Zhen-Mei Chen; Chen-He Yi; Jin Lin; Rui Zhang; Jie Fan; Xiang-Yu Wang; Jin-Hong Chen
Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study
CELL REPORTS MEDICINE
IF10.6
2023-12-011
OAAI
Zhang, Bo; Song, Yan; Luo, Suxia; Yin, Xianli; Li, Enxiao; Wang, Hui; He, Yifu; Liu, Zhihui; Fan, Qingxia; Liang, Xinjun; Shu, Yongqian; Liu, Yunpeng; Xu, Nong; Zhang, Shu; Zhuang, Zhixiang; Zhang, Jingdong; Kou, Xiaoge; Wang, Fen; Zhu, Xiaodong; Zeng, Shan; Wang, Ke; Zhong, Haijun; Li, Shengmian; Bai, Yuxian; Yu, Junyan; Dou, Yiwei; Ma, Taiyang; Liu, Qian; Huang, Jing
First-line serplulimab or placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: a randomized, double-blind phase 3 trial

一线serplulimab或安慰剂联合化疗治疗PD-L1-positive食管鳞状细胞癌: 一项随机，双盲3期试验

NATURE MEDICINE
IF50
2023-02-0271
OAAI
Song, Yan; Zhang, Bo; Xin, Dao; Kou, Xiaoge; Tan, Zhenbo; Zhang, Shu; Sun, Meili; Zhou, Jin; Fan, Min; Zhang, Ming; Song, Yongxiang; Li, Suyi; Yuan, Yuan; Zhuang, Wu; Zhang, Jingdong; Zhang, Li; Jiang, Hao; Gu, Kangsheng; Ye, Huangyang; Ke, Ying; Li, Jing; Wang, Qingyu; Zhu, Jun; Huang, Jing
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial

肿瘤内OH2，溶瘤性单纯疱疹病毒2，在晚期实体瘤患者中: 一项多中心I/II期临床试验

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2021-04-0960
OAAI
Zhang, Bo; Huang, Jing; Tang, Jialin; Hu, Sheng; Luo, Suxia; Luo, Zhiguo; Zhou, Fuxiang; Tan, Shiyun; Ying, Jieer; Chang, Qing; Zhang, Rui; Geng, Chengyun; Wu, Dawei; Gu, Xiangyong; Liu, Binlei

研究方向

暂未获取到该数据
J
Jing Huang
H 指数:31论文数:163被引数:9,891
韩
韩宝惠
H 指数:56论文数:712被引数:1.4万
X
Xingyuan Wang
H 指数:13论文数:100被引数:962
J
Jinhong Chen
H 指数:37论文数:245被引数:5,176
J
Jingdong Zhang
H 指数:30论文数:238被引数:4,998
H
Hongnan Mo
H 指数:21论文数:122被引数:2,416
张
张舒
H 指数:59论文数:594被引数:1.5万
耿
耿燕
H 指数:61论文数:373被引数:1.9万
J
Jun Lü
H 指数:34论文数:244被引数:3,979
D
Dawei Wu
H 指数:33论文数:200被引数:4,334